Your browser doesn't support javascript.
loading
Allele frequency and proportion defined by circulating tumor DNA profiling predict tyrosine kinase inhibitors' therapeutic outcomes for non-small cell lung cancer.
Song, Jiajia; Bai, Ling; Zhai, Jianzhao; Xin, Zhaodan; You, Liting; Zhou, Yi; Zhou, Juan; Ying, Binwu.
Affiliation
  • Song J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China.
  • Bai L; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China.
  • Zhai J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China.
  • Xin Z; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China.
  • You L; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China.
  • Zhou Y; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China.
  • Zhou J; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China. zhoujuan39@qq.com.
  • Ying B; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chendu, Sichuan, China. yingbinwu@scu.edu.cn.
J Cancer Res Clin Oncol ; 149(4): 1531-1540, 2023 Apr.
Article in En | MEDLINE | ID: mdl-35578031

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Circulating Tumor DNA / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Circulating Tumor DNA / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Year: 2023 Type: Article